Portugal's Novo Banco 2024 profit hits record high ahead of IPO
Portugal's fourth-largest lender Novo Banco, which is preparing for an initial public offering (IPO), said on Thursday its ...
GlobalData on MSN17h
Asceneuron halts Alzheimer’s trial adding to tau-targeting setbacks
After Eli Lilly and Biogen’s setbacks in developing O-GlaNAcase (OGA) inhibitors for Alzheimer’s disease, Asceneuron has now ...
NetraMark Holdings Inc.: Netramark Unveils AI Driven Insights for Major Depressive Disorder and Schizophrenia at ISCTM Conference
TORONTO, ON / ACCESS Newswire / March 5, 2025 / NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE:AIAI)(OTCQB:AINMF)(Frankfurt:8TV) a generative AI software leader in clinical trial analytic ...
Novo to Sell Weight-loss Drug Wegovy Directly to Patients
Novo Nordisk A/S is following in rival Eli Lilly & Co.’s footsteps by selling its hit weight-loss drug Wegovy directly to US ...